SONOMA PHARMACEUTICALS, INC. (SNOA) Operating margin 2017–2026
SONOMA PHARMACEUTICALS, INC. (SNOA) operating margin by fiscal year — reported operating income divided by reported revenue.
-12.6%FY2026 · since FY2017: -101.2% → -12.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -12.6% | +13.4 pp |
| FY2025 | -26.0% | +10.9 pp |
| FY2024 | -36.9% | -2.5 pp |
| FY2023 | -34.4% | +12.2 pp |
| FY2022 | -46.6% | -28.1 pp |
| FY2021 | -18.5% | +22.7 pp |
| FY2020 | -41.2% | +18.1 pp |
| FY2019 | -59.3% | +25.8 pp |
| FY2018 | -85.2% | +16.0 pp |
| FY2017 | -101.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SNOA financial trends
SNOA RevenueSNOA Net incomeSNOA Net marginSNOA Gross profitSNOA Gross marginSNOA Operating incomeSNOA Operating cash flowSNOA Free cash flowSNOA Capital expendituresSNOA Return on equitySNOA Stock buybacksSNOA Dividends paidSNOA Total assetsSNOA Total liabilitiesSNOA Shareholders’ equitySNOA overview →